JNJ relationship map
JNJ
Johnson & Johnson
JNJ buys from Healthcare · 16
Healthcare16 · open
Anika TherapeuticsANIK50.00% of ANIK revANIK 10-K
AC ImmuneACIUAddex TherapeuticsADXNAvalo TherapeuticsAVTX2°Apollo AP43 Limited ("Apollo")unlisted
2°Apollo AP43unlisted
BillionToOneBLLN2°Western Alliance Bankunlisted
2°Medicareunlisted
Contineum TherapeuticsCTNM2°WuXi AppTecunlisted
Legend BiotechLEGNMeiraGTxMGTX2°UCL Business Plc (UCLB)unlisted
2°Sanofiunlisted
MerckMRKNanobiotixNBTX2°The University of Texas MD Anderson Cancer Centerunlisted
2°Institut Gustave Roussyunlisted
Protagonist TherapeuticsPTGXRallybioRLYB2°Swedish Orphan Biovitrum AB (Publ)unlisted
ZymeworksZYME2°ProBioGenunlisted
2°Chugai Pharmaceuticalsunlisted
Legend Biotech Irelandunlisted—
Legend Biotech USAunlisted—
Pharmacyclicsunlisted—
Industrials & materials3 ›← Buys from
JNJJohnson & Johnson
ORICOric Pharmaceuticals
2°Mirati Therapeuticsunlisted
2°Voronoiunlisted
2°Bayerunlisted
PCRXPacira BioSciences2°AmerisourceBergen Healthunlisted
VNDAVanda Pharmaceuticals2°Novartis Pharmaunlisted
—Kenvueunlisted
Sells to →
50.00% of ANIK rev10-K
2°Apollo AP43 Limited ("Apollo")unlisted
2°Apollo AP43unlisted
2°Western Alliance Bankunlisted
2°Medicareunlisted
2°WuXi AppTecunlisted
2°UCL Business Plc (UCLB)unlisted
2°Sanofiunlisted
2°The University of Texas MD Anderson Cancer Centerunlisted
2°Institut Gustave Roussyunlisted
2°Swedish Orphan Biovitrum AB (Publ)unlisted
2°ProBioGenunlisted
2°Chugai Pharmaceuticalsunlisted
Legend Biotech Irelandunlisted—
Legend Biotech USAunlisted—
Pharmacyclicsunlisted—
← Buys from
JNJJohnson & Johnson
2°Mirati Therapeuticsunlisted
2°Voronoiunlisted
2°Bayerunlisted
2°AmerisourceBergen Healthunlisted
2°Novartis Pharmaunlisted
—Kenvueunlisted
Sells to →
suppliercustomerunlisted2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 20:32 ETSources